Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

652
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
652
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

1.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Nanovaccines with ferroptosis, necroptosis and STING-activation for synergistic immunotherapy.

Journal of experimental & clinical cancer research : CR·2026
Same author

Nanovaccines with ferroptosis, necroptosis and STING-activation for synergistic immunotherapy.

Journal of experimental & clinical cancer research : CR·2026
Same author

Retrospective multicenter study of thermal ablation outcomes in subcapsular versus intraparenchymal papillary thyroid microcarcinoma.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·2026
Same author

Demonstration of Discrete-Time Quantum Walks and Observation of Topological Edge States in a Superconducting Qutrit Chain.

Physical review letters·2026
Same author

Cascade-penetrating domino-ferroptosis nano inducer synergizes with sonodynamic therapy for anaplastic thyroid cancer.

Materials today. Bio·2025
Same author

<i>MALAT1</i> promotes malignancy of HBV-related hepatocellular carcinoma by regulating IGF2BP3-mediated nuclear-cytoplasmic shuttling.

International journal of biological sciences·2025

Related Experiment Video

Updated: Sep 4, 2025

Sonodynamic Therapy for the Treatment of Glioblastoma Multiforme in a Mouse Model Using a Portable Benchtop Focused Ultrasound System
09:07

Sonodynamic Therapy for the Treatment of Glioblastoma Multiforme in a Mouse Model Using a Portable Benchtop Focused Ultrasound System

Published on: February 10, 2023

2.6K

Recent advances in sonodynamic immunotherapy.

Jia-Rui Du1, Yang Wang1, Zong-Hua Yue1

  • 1Department of Ultrasound, China-Japan Union Hospital of Jilin University, No. 126, Xian Tai Street, Changchun and Jilin, 130000, China.

Journal of Cancer Research and Clinical Oncology
|July 13, 2022
PubMed
Summary
This summary is machine-generated.

Sonodynamic therapy (SDT) enhances tumor immunotherapy by boosting immune responses and reducing side effects. Combining SDT with immunotherapy shows promise for improved cancer treatment outcomes.

Keywords:
ImmuneImmunotherapySonodynamic therapyUltrasound

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.4K
Generation and Quantitative Analysis of Pulsed Low Frequency Ultrasound to Determine the Sonic Sensitivity of Untreated and Treated Neoplastic Cells
09:05

Generation and Quantitative Analysis of Pulsed Low Frequency Ultrasound to Determine the Sonic Sensitivity of Untreated and Treated Neoplastic Cells

Published on: July 22, 2015

11.3K

Related Experiment Videos

Last Updated: Sep 4, 2025

Sonodynamic Therapy for the Treatment of Glioblastoma Multiforme in a Mouse Model Using a Portable Benchtop Focused Ultrasound System
09:07

Sonodynamic Therapy for the Treatment of Glioblastoma Multiforme in a Mouse Model Using a Portable Benchtop Focused Ultrasound System

Published on: February 10, 2023

2.6K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.4K
Generation and Quantitative Analysis of Pulsed Low Frequency Ultrasound to Determine the Sonic Sensitivity of Untreated and Treated Neoplastic Cells
09:05

Generation and Quantitative Analysis of Pulsed Low Frequency Ultrasound to Determine the Sonic Sensitivity of Untreated and Treated Neoplastic Cells

Published on: July 22, 2015

11.3K

Area of Science:

  • Oncology
  • Immunology
  • Biomedical Engineering

Background:

  • Tumor immunotherapy activates immune cells but has limited patient response and can cause adverse events.
  • Sonodynamic therapy (SDT) generates cytotoxic substances, induces apoptosis, and enhances immunity.
  • Combining SDT with immunotherapy presents a promising strategy for cancer treatment.

Purpose of the Study:

  • To review the recent advancements in sonodynamic therapy (SDT) for tumor immunotherapy.
  • To explore the application of SDT-triggered immunotherapy.
  • To summarize the synergistic effects of combining SDT with immunotherapy.

Main Methods:

  • Literature review of recent studies on SDT and immunotherapy.
  • Analysis of SDT's mechanisms in modulating the tumor microenvironment.
  • Evaluation of combined SDT-immunotherapy strategies and their outcomes.

Main Results:

  • SDT can effectively enhance anti-tumor immune responses.
  • Combining SDT with immunotherapy demonstrates improved efficacy compared to monotherapy.
  • SDT may mitigate immune-related adverse events associated with immunotherapy.

Conclusions:

  • Sonodynamic therapy is a potent strategy to augment tumor immunotherapy.
  • The combination of SDT and immunotherapy offers a promising therapeutic approach for various cancers.
  • Further research into SDT-immunotherapy combinations is warranted to optimize clinical applications.